文献速递主动脉疾病

Amplatzer血管塞栓塞治疗TEVAR后Ia型内漏的初步经验

Initial Experience with Amplatzer Vascular Plug Embolization for Type Ia Endoleaks Following Thoracic Endovascular Aortic Repair.
PubMed 文献 · Ann Vasc Surg · 2026-07-16

本研究评估Amplatzer血管塞(AVP)栓塞治疗胸主动脉腔内修复(TEVAR)后Ia型内漏的安全性和可行性。12例主动脉夹层患者经假腔在內漏旁释放AVP,技术成功率100%,即刻造影成功率91.7%,中位随访16个月无内漏复发或器械相关并发症。

要点

  • AVP栓塞治疗TEVAR后Ia型内漏技术可行,即刻造影成功率高。
  • 中位随访16个月,初始完全闭塞者无内漏复发,无器械相关并发症。
  • 假腔平均缩小40.0±28.6%,尤其适用于不规则或复杂内漏。

核心结论

  • AVP栓塞是TEVAR后Ia型内漏可行且潜在有效的治疗选择,尤其适用于不规则或复杂内漏。

研究设计与样本

  • 回顾性单中心初步研究,纳入2020年1月至2025年5月12例TEVAR后发生Ia型内漏的主动脉夹层患者。
  • 所有患者均经假腔在内漏旁释放Amplatzer血管塞(AVP)进行栓塞。

主要发现

  • 12例患者AVP均成功释放,技术成功率100%,即刻造影成功率91.7%。
  • 术后造影显示假腔内无明显血流,假腔平均缩小40.0±28.6%。
  • 中位随访16个月(范围3-48个月),11例初始完全闭塞者无内漏复发。
  • 1例因内漏大且不规则需分期栓塞,未观察到AVP相关并发症(包括器械移位或内漏扩大)。

临床怎么用

  • 对于TEVAR后Ia型内漏,尤其是不规则或复杂内漏,可考虑经假腔途径行AVP栓塞。
  • 术后需用CTA随访评估栓塞效果和内漏状态。

局限性

  • 样本量小(12例),为单中心初步经验,需更大规模研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Type Ia endoleaks (T1aELs) are a common complication after thoracic endovascular aneurysm repair (TEVAR) and remain challenging to manage in patients with aortic dissection. This study presents our initial experience with the Amplatzer vascular plugs (AVPs) for embolization of T1aELs. This study aimed to evaluate the safety and feasibility of AVPs embolization for T1aELs after TEVAR. METHODS: From January 2020 to May 2025, 12 patients with aortic dissection who developed T1aELs after TEVAR underwent embolization with AVPs. The plugs were deployed adjacent to the endoleak through the false lumen (FL). Follow-up computed tomography angiography (CTA) was performed to evaluate the effectiveness of AVP embolization and the status of the endoleak. RESULTS: AVPs were successfully deployed in all 12 patients, with subsequent angiography showing no significant blood flow in the FL. The mean FL shrinkage was 40.0 ± 28.6%. The technical success rate was 100%, and the immediate angiographic success rate was 91.7%. During a median follow-up of 16 months (range: 3-48 months), no recurrence of T1aEL was observed in the 11 patients who achieved initial complete occlusion. One patient required staged embolization because of a large, irregular endoleak. No AVP-related complications were observed, including device migration or enlargement of the endoleak. CONCLUSION: In our experience, AVP embolization is a feasible and potentially effective treatment option for T1aELs following TEVAR, especially for irregular or complex endoleaks. Further large-scale studies are warranted to confirm these findings.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Peng HH, Liu Z, Fang QB, et al. Initial Experience with Amplatzer Vascular Plug Embolization for Type Ia Endoleaks Following Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2026. PMID: 42462905. doi:10.1016/j.avsg.2026.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。